Angiotensin III increases MCP-1 and activates NF-κB and AP-1 in cultured mesangial and mononuclear cells

Kidney International

Volumn 57, Issue 6, 2000, Pages 2285-2298

  Ruiz Ortega, Marta ^a   Lorenzo, Oscar ^a   Egido, Jesus ^a,b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

Activating protein 1; Ang III; Inflammation; Kidney; Monocyte chemoattractant protein 1; Nuclear factor B; Renin angiotensin system

Indexed keywords

ANGIOTENSIN III; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN KAPPA CHAIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ARTICLE; CELL INFILTRATION; CHEMOTAXIS; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATORY CELL; MESANGIUM CELL; MONOCYTE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0034074843     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00089.x     Document Type: Article

References (63)

1. 1. ERDOS EG, SKIDGEL RA: Renal metabolism of Ang I and Ang II. Kidney Int 38:524-527, 1990
2. 2. WOLF G, NEILSON EG: Angiotensin II as a renal growth factor. J Am Soc Nephrol 3:1531-1540, 1993
3. 3. EGIDO J: Vasoactive hormones and renal sclerosis. Kidney Int 49:578-597, 1996
4. 4. ARDAILLOU R, CHANSEL D: Synthesis and effects of active fragments of angiotensin II. Kidney Int 52:1458-1468, 1997
5. 5. LINDPAINTER K, GARTEN D: The cardiac renin angiotensin system: An appraisal of experimental and clinical evidence. Circ Res 68:905-921, 1991
6. 6. GOODFRIEND TL, PEACH MJ: Angiotensin III:(Des-aspartatic acid)-angiotensin II: Evidence and speculation for its role as an important agonist in the renin angiotensin system. Circ Res 36:138-148, 1975
7. 7. BLAIR-WEST JR, COGHLAN JP, DENTON DA, FUNDER JW, SCOGGINS BA, WRIGHT RD: The effect of the heptapeptide (2-8) and heptapeptide (3-8) fragments of Ang II on aldosterone secretion. J Clin Endocrinol Metab 32:575-578, 1971
8. 8. PENDLETON RG, GEORGE G, HORNE E: Comparative effects of angiotensin II and angiotensin III in rabbit adrenal and aortic tissues. J Pharmacol Exp Rev 256:614-620, 1991
9. 1] Angiotensin II: Mediator of the renin angiotensin system? Fed Proc 36:1766-1770, 1977
10. 10. LI Q, ZHANG J, PFAFFENDORF M, VAN-ZIETEN PA: Direct positive chronotropic effects of angiotensin II and angiotensin III in pithed rats and in rat isolated atria. Br J Pharmacol 118:1653-1658, 1996
11. 11. YANG CC, KUO TB, CHAN SH, CHAN JY: Neurobiology of central angiotensin III and dipsogenesis. Biol Signals 4:59-71, 1995
12. 12. ZINI S, FOURNIE-ZALUSKI MC, CHAUVEL E, ROQUES BP, CORVOL P, LLORENS-CORTES C: Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: Predominant role of angiotensin III in the control of vasopressin release. Proc Natl Acad Sci USA 93:11968-11973, 1996
13. 13. KUGLER P, WOLF G, SCHERBERICH J: Histochemical demonstration of peptidases in the human kidney. Histochemistry 83:337-341, 1985
14. 14. STEFANOVIC V, VLAHOVIC P, ARDAILLOU N, RONCO P, ARDAILLOU R: Cell surface aminopeptidase A and N activities in human glomerular epithelial cells. Kidney Int 41:1571-1580, 1992
15. 15. KUGLER P: Localization of aminopeptidase A (angiotensinase A) in the rat and mouse kidney. Histochemistry 72:269-278, 1981
16. 16. TROYANOVSKAYA M, SONG L, JAYARAMAN G, HEALY DP: Expression of aminopeptidase A, an angiotensinase, in glomerular mesangial cells. Hypertension 27:518-522, 1996
17. 17. WOLF G, THAISS F, MULLAER E, DISSER M, POOTH R, ZAHNER G, STHAL RKA: Glomerular mRNA expression of angiotensinase A after renal ablation. Exp Nephrol 3:240-248, 1995
18. 18. THAISS F, WOLF G, ASSAD N, ZAHNER G, STHAL RKA: Angiotensinase A gene expression and activity in isolated glomeruli of diabetic rats. Diabetologia 39:275-280, 1996
19. 19. SONG L, HEALY DP: Kidney aminopeptidase A and hypertension. Hypertension 33:746-752, 1999
20. 20. SEIKALY MG, ARANT BS, SENEY FD: Endogenous angiotensin concentration in specific intrarenal fluid compartment of the rat. J Clin Invest 86:1352-1357, 1990
21. 21. TERUI J, TAMOTO K, SUDO J: Proteinuric potentials of angiotensin II, [des-Asp1]-angiotensin II, and [des-Asp1, des-Arg2]-angiotensin II in rats. Biol Pharm Bull 17:1516-1518, 1994
22. 22. RUIZ-ORTEGA M, LORENZO O, EGIDO J: Angiotensin III upregulates genes involved in kidney damage in cultured mesangial cells and renal interstitial fibroblast. Kidney Int 54(Suppl 68):S41-S45, 1998
23. 23. RUIZ-ORTEGA M, BUSTOS C, HERNÁNDEZ-PRESA MA, LORENZO O, PLAZA JJ, EGIDO J: Angiotensin II participates in mononuclear cell recruitment in the kidney through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 gene expression. J Immunol 161:430-439, 1998
24. 24. SCHLONDORF D: The role of chemokines in the initiation and progression of renal disease. Kidney Int 47(Suppl 49):S44-S47, 1995
25. 25. ROVIN BH, RUMANICK M, TAN L, DICKERSON J: Glomerular expression of monocyte chemotactic peptide-1 in experimental and human glomerulonephritis. Lab Invest 71:536-540, 1994
26. 26. TANG WW, QI M, WARREN JS: Monocyte chemoattractant protein-1 mediates glomerular macrophage infiltration in anti-GBM Ab GN. Kidney Int 50:665-670, 1996
27. 27. GONZÁLEZ-CUADRADO S, BUSTOS C, RUIZ-ORTEGA M, ORTIZ A, GUIJARRO C, PLAZA JJ, EGIDO J: Expression of leukocyte chemoattractants by interstitial renal fibroblasts: Up-regulation by drugs associated with interstitial fibrosis. Clin Exp Immunol 106:518-522, 1996
28. 28. HERNÁNDEZ-PRESA MA, BUSTOS C, ORTEGO M, TUÑÓN J, RENEDO G, RUIZ-ORTEGA M, EGIDO J: Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-κB activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 95:1532-1541, 1997
29. 29. WEINSTOCK JV, KASSAB JT: Angiotensin II stimulation of granuloma macrophages phagocytosis and actin polymerization in murine schistosomiasis mansoni. Cell Immunol 89:46-54, 1984
30. 30. HANH AW, JONAS U, BÜHLER FR, RESINK TJ: Activation of human peripheral monocytes by angiotensin II. FEBS Lett 347:178-180, 1994
31. 31. YAMAMOTO Y, YAMAMGUCHI T, SHIMAMURA M, HAZATO T: Angiotensin III is a new chemoattractant for polymorphonuclear leukocytes. Biochem Biophys Res Commun 193:1038-1043, 1993
32. 32. BARNES PJ, KARIN M: Nuclear factor-κB: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071, 1997
33. 33. BEAUPARLANT P, HISCOTT J: Biological and biochemical inhibitors of the NF-κB/rel proteins and cytokine synthesis. Cytokine Growth Factor Rev 7:175-190, 1996
34. 34. KARIN M, LUI Z, ZANDI E: AP-1 function and regulation. Curr Opin Cell Biol 9:240-246, 1997
35. 35. MENÉ P, SIMONSON MS, DUNN MJ: Physiology of the mesangial cell. Physiol Rev 69:1347-1424, 1989
36. 36. CHOMCZYNSKI P, SACCHI N: Single-step of RNA isolation by acid guanidinium thiocyanate-phenol-cloroform extraction. Anal Biochem 162:156-159, 1987
37. 37. FALK W, GOODWIN RH, LEONARD EJ: A 48 well microchemotaxis assembly for rapid and accurate measurement of leukocyte migration. J Immunol Methods 33:239-243, 1980
38. 38. CROSS AK, RICHARSON V, ALI SA, PALMER I, TAUB DD, REES RC: Migration responses of human monocyte cell lines to alpha and beta-chemokines. Cytokine 9:521-528, 1997
39. 39. ROVIN BH, YOSHIUMURA T, TAN L: Cytokine-induced production of monocyte chemoattractant protein-1 by cultured human mesangial cells. J Immunol 148:2148-2153, 1992
40. 40. DUQUE N, GÓMEZ-GUERRERO C, EGIDO J: Interaction of IgA with Fcα receptors of human mesagial cells activates transcription factor nuclear-κB and induces expression and synthesis of monocyte chemoattractant protein-1, IL-8 and IFN-inducible protein 10. J Immunol 159:3474-3481, 1997
41. 41. ROVIN BH, DICKERSON JA, TAN LC, HEBERT CA: Activation of nuclear factor-κB correlates with MCP-1 expression by human mesangial cells. Kidney Int 48:1263-1271, 1995
42. 42. UEDA A, OKUDA K, OHNO S, SHIRAI A, IGARASHI T, MATSUNAGA K, FUKUSHIMA J, KAWAMOTO S, ISHIGATSUBO Y, OKUBO T: NF-κB and SP1 regulate transcription of the human monocyte chemoattractant protein 1 gene. J Immunol 153:2052-2063, 1994
43. 43. ROBERTSON MJ, CUNOSAMY MP, CLARK KL: Effects of peptidases inhibition on angiotensin receptor agonist and antagonist potency on rabbit isolated thoracic aorta. Br J Pharmacol 106:166-172, 1992
44. 3H]angiotensin II binding in pig aorta. Eur J Pharmacol 215:259-264, 1992
45. 45. BAUERLE PA, BALTIMORE DI: I kappa B: A specific inhibitor of the NF-κB transcription factor. Science 242:540-546, 1998
46. 46. BAUERLE PA, BALTIMORE D: A 65-kD subunit of active NF-κB is required for inhibition of NF-κB by I-κB. Genes Dev 3:1689-1692, 1989
47. 47. SIEBENLIST U, FRANZOSO G, BROWN K: Structure, regulation and function of NF-κB. Annu Rev Cell Biol 10:405-455, 1994
48. 48. FIEDLER MA, WERNKE-DOLLRIES K, STARK JM: Inhibition of TNF-α-induced NF-κB activation and IL-8 release in A549 cells with the proteasome inhibitor MG-132. Am J Respir Cell Mol Biol 19:259-268, 1998
49. 49. MARTIN T, CARDARELLI PM, PARRY GCN, FELTS KA, COBBS RR: Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-κB and AP-1. Eur J Immunol 27:1091-1097, 1997
50. 50. HAMAGUCHI A, KIM S, YANO M, YAMANAKA S, IWAO H: Activation of glomerular mitogen-activated kinases in angiotensin II-mediated hypertension. J Am Soc Nephrol 9:372-380, 1998
51. 51. HISADA Y, SUGAYA T, YAMANOUCHI M, UCHIDA H, FUJIMURA H, SAKURAI H, FUKAMIZU A, MURAKAMI K: Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice. J Clin Invest 103:627-635, 1999
52. 52. CAPERS Q, ALEXANDER RW, DE LOU P, LEON H, WILCOX JN, HOWARD AB, TAYLOR WR: Monocyte chemoattractant protein 1 expression in aortic tissues of hypertensive rats. Hypertension 30:1397-1402, 1997
53. 53. WENZEL U, SCHNEIDER A, VALENTE AJ, ABBOUD HE, THAISS F, HELMCHEN UM, STAHL RA: Monocyte chemoattractant protein-1 mediates monocyte/macrophage influx in anti-thymocyte antibody-induced glomerulonephritis. Kidney Int 51:770-776, 1997
54. 54. WOLF G, ZIYADEH FN, THAISS F, TOMASZEWISKI J, CARON RJ, WENZEL U, ZAHNER G, HELMCHEN U, STAHL RA: Angiotensin II stimulates expression of the chemokines RANTES in rat glomerular endothelial cells: Role of the angiotensin type 2 receptor. J Clin Invest 100:1047-1058, 1997
55. 55. FABER HW, CENTER DM, ROUNDS S, DANILOV SM: Components of the renin angiotensin system cause release of a neutrophil chemoattractant from cultured bovine and human endothelial cells. Eur Heart J 11:100-107, 1990
56. 56. ICHIKAWA I, HARRIS RC: Angiotensin actions in the kidney: Renewed insight into the old hormone. Kidney Int 40:583-596, 1991
57. 2+ signaling and c-fos expression. Eur J Pharmacol 362:235-243, 1998
58. 58. CATALIOTO RM, RENZETTI AR, CRISCUOLI M, MORBIDELLI L, SUBISSI A: Role of calcium in angiotensin II-induced prostanglandin release and DNA synthesis in rat vascular smooth muscle cells. J Cardiovasc Pharmacol 27:195-200, 1996
59. 59. WENDT T, ZHANG YM, BIERHAUS A, KRIEGSMANN J, DENG Y, WALDEHERR R, TESKE T, LUTHER T, FÜNESTÜCK R, NAWROTH PP, STFIN G: Tissue factor expression in an animal model of hydronephrosis. Nephrol Dial Transplant 10:1820-1828, 1995
60. 60. MORRISSEY JJ, KLAHR S: Enalapril decreases nuclear factor kappa B activation in the kidney with ureteral obstruction. Kidney Int 52:926-933, 1997
61. 61. SAKURAI H, SHIGEMORI N, HISADA Y, ISHIZUKA T, KAWASHIMA K, SUGITA T: Suppression of NF-kappa B and AP-1 activation by glucocorticoids in experimental glomerulonephritis in rats. Biochim Biophys Acta 31:252-262, 1997
62. 62. CHENG DY, DEWITT BJ, MCMAHON TJ, KADOWITZ PJ: Comparison of pressor responses to angiotensin I, II and III in pulmonary vascular beds of cats. Am J Physiol 266:H2247-H2255, 1994
63. 63. GARRISON EA, SANTIAGO JA, OSEI SY, KADOWITZ PJ: Analysis of responses to angiotensin peptides in the hindquarters vascular bed of the cat. Am J Physiol 268:H2418-H2425, 1995